• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎患者严重缺血性并发症的高发生率,与血小板计数、大小及血小板抑制无关。

High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.

作者信息

Berger C T, Wolbers M, Meyer P, Daikeler T, Hess C

机构信息

Department of Internal Medicine, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.

出版信息

Rheumatology (Oxford). 2009 Mar;48(3):258-61. doi: 10.1093/rheumatology/ken480. Epub 2009 Jan 7.

DOI:10.1093/rheumatology/ken480
PMID:19129348
Abstract

OBJECTIVE

Vision loss and ischaemic stroke are feared complications in GCA. We investigated how platelet count and size and platelet inhibition with ASA relate to ischaemic complications in patients with GCA.

METHODS

Charts of patients with GCA were retrospectively analysed. Jaw claudication, amaurosis fugax, blurred vision, ischaemic stroke and permanent visual loss were classified as 'ischaemic events'; ischaemic stroke and permanent visual loss were sub-grouped as 'severe ischaemic events'. The incidence of ischaemia and the association to the pre-defined covariates age, fever, ESR, platelet count and size and ASA treatment were assessed.

RESULTS

Eighty-five patients (mean age 73 yrs, 60% women, 78% biopsy-proven) were included in the analysis. Of the 85 patients, 62 (73%) presented with ischaemic events, 29/85 patients (34%) with severe ischaemic events. At the time of diagnosis 22/85 patients (26%) were treated with ASA. Of these 22 patients, 15 (68%) presented with ischaemic events, 7/22 patients (32%) with severe ischaemic events. In multivariate analysis, neither platelet count nor size or ASA treatment were significantly associated with ischaemic or severe ischaemic events.

CONCLUSIONS

The incidence of severe ischaemic events in patients with GCA was high, irrespective of platelet count and size and established ASA treatment.

摘要

目的

视力丧失和缺血性中风是巨细胞动脉炎(GCA)中令人担忧的并发症。我们研究了血小板计数、大小以及阿司匹林(ASA)对血小板的抑制作用与GCA患者缺血性并发症之间的关系。

方法

对GCA患者的病历进行回顾性分析。将颌部间歇性运动障碍、一过性黑矇、视力模糊、缺血性中风和永久性视力丧失归类为“缺血性事件”;缺血性中风和永久性视力丧失被进一步归类为“严重缺血性事件”。评估缺血的发生率以及与预先定义的协变量年龄、发热、红细胞沉降率(ESR)、血小板计数、大小和ASA治疗之间的关联。

结果

85例患者(平均年龄73岁,60%为女性,78%经活检证实)纳入分析。85例患者中,62例(73%)出现缺血性事件,29/85例患者(34%)出现严重缺血性事件。诊断时,22/85例患者(26%)接受了ASA治疗。在这22例患者中,15例(68%)出现缺血性事件,7/22例患者(32%)出现严重缺血性事件。多变量分析显示,血小板计数、大小或ASA治疗与缺血性或严重缺血性事件均无显著关联。

结论

GCA患者严重缺血性事件的发生率较高,与血小板计数、大小及既定的ASA治疗无关。

相似文献

1
High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.巨细胞动脉炎患者严重缺血性并发症的高发生率,与血小板计数、大小及血小板抑制无关。
Rheumatology (Oxford). 2009 Mar;48(3):258-61. doi: 10.1093/rheumatology/ken480. Epub 2009 Jan 7.
2
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.巨细胞动脉炎患者的抗血小板和抗凝治疗。
Arthritis Rheum. 2006 Oct;54(10):3306-9. doi: 10.1002/art.22141.
3
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.低剂量阿司匹林与巨细胞动脉炎颅缺血性并发症的预防
Arthritis Rheum. 2004 Apr;50(4):1332-7. doi: 10.1002/art.20171.
4
The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.红细胞沉降率与经活检证实的巨细胞动脉炎患者视觉并发症的发生有关。
Semin Arthritis Rheum. 2008 Oct;38(2):116-23. doi: 10.1016/j.semarthrit.2007.10.014. Epub 2008 Jan 25.
5
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.意大利一项基于人群的巨细胞动脉炎患者队列中严重颅脑缺血事件的危险因素。
Rheumatology (Oxford). 2009 Mar;48(3):250-3. doi: 10.1093/rheumatology/ken465. Epub 2008 Dec 24.
6
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.巨细胞(颞)动脉炎中强烈炎症反应与视力丧失及其他头颅缺血性并发症低发生风险之间的关联。
Arthritis Rheum. 1998 Jan;41(1):26-32. doi: 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0.
7
Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack.缺血性中风和短暂性脑缺血发作后早期和晚期循环中的网织血小板
Br J Haematol. 2004 Sep;126(6):861-9. doi: 10.1111/j.1365-2141.2004.05137.x.
8
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.基于意大利人群的巨细胞动脉炎患者队列中视力丧失的危险因素。
Arthritis Rheum. 2005 Apr 15;53(2):293-7. doi: 10.1002/art.21075.
9
Variable platelet response to aspirin in patients with ischemic stroke.缺血性中风患者对阿司匹林的血小板反应存在差异。
Cerebrovasc Dis. 2007;24(1):43-50. doi: 10.1159/000103115. Epub 2007 May 22.
10
Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.首次缺血性卒中后患者血浆甘油三酯作为血小板对阿司匹林反应性的预测指标
Cerebrovasc Dis. 2008;26(3):272-6. doi: 10.1159/000147455. Epub 2008 Jul 23.

引用本文的文献

1
Interdisciplinary approach in the management of visual loss in giant cell arteritis.巨细胞动脉炎所致视力丧失管理中的多学科方法。
Saudi J Ophthalmol. 2024 Nov 18;39(1):14-19. doi: 10.4103/sjopt.sjopt_236_24. eCollection 2025 Jan-Mar.
2
Headache as the most common manifestation of giant cell arteritis?: a systematic review with meta-analysis.头痛是巨细胞动脉炎最常见的表现吗?一项荟萃分析的系统评价
Rheumatol Int. 2025 Feb 11;45(3):47. doi: 10.1007/s00296-025-05803-9.
3
Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review.
影响巨细胞动脉炎脑血管缺血事件的危险因素及药物干预:一项叙述性综述
Immun Inflamm Dis. 2025 Jan;13(1):e70122. doi: 10.1002/iid3.70122.
4
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study.原发性系统性血管炎的卒中频率、相关因素及临床特征:一项多中心观察性研究。
J Neurol. 2024 Jun;271(6):3309-3320. doi: 10.1007/s00415-024-12251-1. Epub 2024 Mar 12.
5
Giant-cell arteritis related strokes: scoping review of mechanisms and rethinking treatment strategy?巨细胞动脉炎相关卒中:机制的范围综述及治疗策略的重新思考?
Front Neurol. 2023 Dec 7;14:1305093. doi: 10.3389/fneur.2023.1305093. eCollection 2023.
6
Giant cell arteritis-related cerebrovascular ischemic events: a French retrospective study of 271 patients, systematic review of the literature and meta-analysis.巨细胞动脉炎相关脑血管缺血事件:271 例法国回顾性研究,文献系统回顾和荟萃分析。
Arthritis Res Ther. 2023 Jul 7;25(1):116. doi: 10.1186/s13075-023-03091-x.
7
Vascular flow limitations affecting the cervico-cranial region: Understanding ischaemia.影响颈颅区域的血管血流限制:理解缺血。
Braz J Phys Ther. 2023 May-Jun;27(3):100493. doi: 10.1016/j.bjpt.2023.100493. Epub 2023 Mar 17.
8
Evidence-based Role of Aspirin in Giant Cell Arteritis: A Literature Review.阿司匹林在巨细胞动脉炎中的循证作用:文献综述
J Community Hosp Intern Med Perspect. 2022 Sep 9;12(5):11-16. doi: 10.55729/2000-9666.1072. eCollection 2022.
9
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.托珠单抗治疗巨细胞动脉炎眼部受累:471例患者的多中心研究
Ther Adv Musculoskelet Dis. 2022 Jul 22;14:1759720X221113747. doi: 10.1177/1759720X221113747. eCollection 2022.
10
Looking ahead: giant-cell arteritis in 10 years time.展望未来:十年后的巨细胞动脉炎。
Ther Adv Musculoskelet Dis. 2022 May 24;14:1759720X221096366. doi: 10.1177/1759720X221096366. eCollection 2022.